Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Guillain-Barré Syndrome
Guillain-Barré Syndrome
RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest
Stat
Thu, 02/29/24 - 07:01 pm
RSV
vaccines
Pfizer
GSK
Guillain-Barré Syndrome
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity
Yahoo/Reuters
Mon, 03/21/22 - 10:24 am
COVID-19
vaccines
Bell's Palsy
Guillain-Barré Syndrome
anxiety
depression
J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says
Stat
Mon, 07/12/21 - 11:46 pm
JNJ
FDA
vaccines
COVID-19
Guillain-Barré Syndrome
FDA adds Guillain-Barré syndrome warning to GlaxoSmithKline’s shingles vaccine
Endpoints
Thu, 03/25/21 - 10:53 pm
GSK
Shingrix
vaccines
shingles
Guillain-Barré Syndrome
FDA
FDA grants fast track status to Annexon’s ANX005 to treat Guillain-Barré Syndrome
Pharmaceutical Business Review
Wed, 09/25/19 - 09:12 am
Annexon
fast track
FDA
ANX005
Guillain-Barré Syndrome